Literature DB >> 11606077

Cytokine profile of cervical cancer cells.

S Hazelbag1, G J Fleuren, J J Baelde, E Schuuring, G G Kenter, A Gorter.   

Abstract

OBJECTIVE: In patients with cervical carcinoma, the presence of cytokines produced by T(H)2 cells, and the presence of an eosinophilic inflammatory infiltrate, has been associated with a less effective immune response and tumor progression. In the present study, we have investigated the cytokine profile of cervical carcinoma cells. In addition, we have measured whether differences in cytokine profiles between normal and malignant cervical epithelial cells are present.
METHODS: For this purpose we have determined the mRNA expression patterns of 20 relevant cytokines by RT-PCR and Southern blotting in 3 normal primary cervical epithelial cell cultures (NPE) and 10 cervical cancer cell lines (CCCL).
RESULTS: TGF-beta(1), IL-4, IL-12p35, and IL-15 were produced by all CCCL and NPE. TNF-alpha, IL-10, IL-5, and RANTES were present in most NPE, but not in any of the CCCL. MCP-1 was expressed in all CCCL but in only one NPE. The presence of the anti-inflammatory cytokine TGF-beta(1) in cervical carcinomas was confirmed by RNA in situ hybridization on tissue sections of carcinomas from which the CCCL originated.
CONCLUSIONS: Our results suggest that cervical carcinoma cells produce immunomodulatory cytokines and that cytokine expression patterns change after malignant transformation. The implications of locally produced cytokines by cervical cancer cells are further discussed. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606077     DOI: 10.1006/gyno.2001.6378

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

Review 1.  Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Authors:  Slawomir Wojtowicz-Praga
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

Review 2.  Pattern recognition for predictive, preventive, and personalized medicine in cancer.

Authors:  Tingting Cheng; Xianquan Zhan
Journal:  EPMA J       Date:  2017-03-09       Impact factor: 6.543

3.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Authors:  Judith N Kloth; Jan Oosting; Tom van Wezel; Karoly Szuhai; Jeroen Knijnenburg; Arko Gorter; Gemma G Kenter; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  BMC Genomics       Date:  2007-02-20       Impact factor: 3.969

4.  Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression.

Authors:  Alexandra Fullár; József Dudás; Lászlóné Oláh; Péter Hollósi; Zoltán Papp; Gábor Sobel; Katalin Karászi; Sándor Paku; Kornélia Baghy; Ilona Kovalszky
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

Review 5.  Pro-tumor activities of macrophages in the progression of melanoma.

Authors:  Huafeng Wang; Luhong Yang; Dong Wang; Qi Zhang; Lijuan Zhang
Journal:  Hum Vaccin Immunother       Date:  2017-04-25       Impact factor: 3.452

6.  Immunotherapy of human papilloma virus induced disease.

Authors:  Sjoerd H van der Burg
Journal:  Open Virol J       Date:  2012-12-28

7.  Genetic susceptibility of cervical cancer.

Authors:  Xiaojun Chen; Jie Jiang; Hongbing Shen; Zhibin Hu
Journal:  J Biomed Res       Date:  2011-05

8.  Role of IL-12p40 in cervical carcinoma.

Authors:  H J M A A Zijlmans; S Punt; G J Fleuren; J B Trimbos; G G Kenter; A Gorter
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

9.  Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells.

Authors:  Nanyan Jiang; Zhiqiang Tian; Jun Tang; Rongying Ou; Yunsheng Xu
Journal:  Mediators Inflamm       Date:  2015-07-15       Impact factor: 4.711

10.  Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.

Authors:  Nunzia Zanotta; Maria Lina Tornesello; Clorinda Annunziata; Giovanni Stellato; Franco Maria Buonaguro; Manola Comar
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.